Navigation Links
Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the People's Republic of China
Date:3/10/2009

HANGZHOU, China and CARSON CITY, Nev., March 10 /PRNewswire-FirstCall/ -- Niusule Biotech Corp. (OTC Bulletin Board: NIUS) announces that its new Venture, Niusule Bioengineering (Hangzhou) Co., Ltd., has been formally established by obtaining the "Certificate of Approval for Establishment of Enterprises with Foreign Investment in the People's Republic of China" from Zhejiang Foreign Trade & Economic Cooperation Bureau on March 2, 2009 and the Business License from Hangzhou Industrial and Commerce on March 4, 2009.

The development of the Venture will continue by:

  • Submitting the application to Hangzhou Administration of Foreign Exchange for the Foreign Exchange Registration Certificate of Foreign-funded Enterprise of Niusule Bioengineering (Hangzhou) Co., Ltd. in March 2009.
  • Submitting the application to Zhejiang Food and Drug Administration for the approval of health food used in Zhejiang Province in April 2009.

Niusule Biotech Corp. will continue the development of its business plan by:

  • Signing production agreements with certain U.S. health food manufacturers in March 2009. We are currently assessing suppliers, products and quantities.
  • Executing the distribution agreement with Niusule Bioengineering (Hangzhou) Co., Ltd. in late March 2009, which we need to do in order to import and sell our products in China.

When Niusule Bioengineering (Hangzhou) Co., Ltd. is established and approved by government regulatory authorities, we plan to open 10 Niusule Health Food Stations in Zhejiang province to sell health food products, focusing on products imported from the U.S.

"This new venture signals our commitment to being a leading player in China's health food industry," said Chairman Mrs. Qinghua Hu of Niusule Biotech Corp. "We believe that China has witnessed significant economic growth during recent years and that more people have attained the means and desire to have a healthy lifestyle. We are confident in our bright future and welcome qualified companies to cooperate with us."

About Niusule Biotech Corp.

Niusule Biotech Corp, through its wholly-owned subsidiary, Niusule Bioengineering (Hangzhou) Co., Ltd., plans to sell in China, various health food and related products some of which it intends to import from the U.S.

Safe Harbor Statement

The statements contained herein that are not historical facts are 'forward-looking statements' within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as 'believes,' 'expects,' 'may,' 'will,' 'should,' or 'anticipates,' 'expect' or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets or forecasting financial results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.


'/>"/>
SOURCE Niusule Biotech Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Niusule Biotech Corp. to Commence Trading on the OTC Bulletin Board Under the Symbol NIUS
2. Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ
3. Sinovac Biotech Co. Ltd., Sinovacs Beijing Subsidiary, Obtains High-Tech Enterprise Status
4. Canadian Government Announces Funding for Leading Biotechnology Firms Project
5. InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies
6. Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008
7. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
8. FDA Provides A Positive Review of InNexus Biotechnology Development Plan for Lead Product
9. Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener
10. Morningstar Healthcare Analysts to Discuss Top 15 Biotech Acquisition Targets on Wednesday, March 4 at 11 a.m. EST
11. PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprovas Enantiomers of DOTAP Chloride in Immunotherapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... 12, 2017   Protein Sciences Corporation , ... Flublok Influenza Vaccine ®, announced today that ... good safety results and induced strong neutralizing antibodies ... product is expected to advance into human clinical ... the Institute of Technology in Immunobiologicals of the ...
(Date:1/12/2017)... , ... January 12, 2017 ... ... rapid adoption of Limfinity® Cloud, RURO has enhanced the platform to accommodate ... groups, federated login, rapid data searching, and more. In addition to these ...
(Date:1/11/2017)... ... January 11, 2017 , ... As a ... Peru studying the pathogens that cause malaria and tuberculosis. Seeing firsthand the ravages ... discovery. , Now, as an assistant professor of biology and biotechnology at Worcester ...
(Date:1/11/2017)... Yorba Linda, Ca (PRWEB) , ... January 11, ... ... in the U.S. each year and costing healthcare systems more than $23.7 billion, ... patients while controlling costs. , Among the most common sepsis-causing pathogens are ...
Breaking Biology Technology:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... , Dec 16, 2016 Research and ... System Market - Global Forecast to 2021" report to their ... The ... to grow at a CAGR of 14.06% from 2016 to 2021. ... and is projected to reach 854.8 Million by 2021. The growth ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
Breaking Biology News(10 mins):